Pulse Biosciences Inc logo

Pulse Biosciences Inc

$ 1.84 -0.11 (-5.64%) 10:31 AM EST
P/E:
At Loss
P/B:
10.82
Market Cap:
$ 68.50M
Enterprise V:
$ 78.77M
Volume:
10.73K
Avg Vol (2M):
276.98K
Also Trade In:
Volume:
10.73K
Market Cap $:
68.50M
PE Ratio:
At Loss
Avg Vol (2-Month):
276.98K
Enterprise Value $:
78.77M
PB Ratio:
10.82
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Pulse Biosciences Inc is a medical therapy company that pursues the commercial introduction of its proprietary CellFX System utilizing its patent-protected Nano-Pulse Stimulation (NPS) platform technology. Through its proprietary CellFX System, the company can deliver a cell-focused effect on dysfunctional cells while preserving surrounding non-cellular tissue, a combination that may potentially lead to both improved efficacy and less collateral tissue damage. Substantial revenue is generated from North America Majorly due to the sale of systems.
Name Current Vs Industry Vs History
Cash-To-Debt 0.92
Equity-to-Asset 0.07
Debt-to-Equity 12.17
Debt-to-EBITDA -1.19
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -5.59
Distress
Grey
Safe
Beneish M-Score -3.8
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 56.92
9-Day RSI 49.4
14-Day RSI 48.49
12-1 Month Momentum % -89.97

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.17
Quick Ratio 10.06
Cash Ratio 9.88
Days Inventory 160.88
Days Sales Outstanding 7.85
Days Payable 80.19

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -13
Name Current Vs Industry Vs History
Gross Margin % -665.87
Operating Margin % -4167.55
Net Margin % -4167.68
ROE % -242.45
ROA % -111.94
ROIC % -291.75
ROC (Joel Greenblatt) % -544.26
ROCE % -130.7

Financials (Next Earnings Date:2023-02-10 Est.)

PLSE's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:PLSE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.553
EPS (TTM) ($) -2.03
Beta 1.12
Volatility % 119.81
14-Day RSI 48.49
14-Day ATR ($) 0.212762
20-Day SMA ($) 1.9845
12-1 Month Momentum % -89.97
52-Week Range ($) 1.18 - 21.64
Shares Outstanding (Mil) 37.23

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Pulse Biosciences Inc Filings

Document Form Filing Date
No Filing Data

Pulse Biosciences Inc Analysis

Share your research

Headlines

See More
No news.